Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 Levels.

Cancer prevention research (Philadelphia, Pa.)Ā·2026
Same author

Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet).

Frontiers in immunologyĀ·2026
Same author

Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trials.

Nature communicationsĀ·2026
Same author

Publisher Correction: Multi-ancestry genome-wide association study of severe pregnancy nausea and vomiting.

Nature geneticsĀ·2026
Same author

Multi-ancestry genome-wide association study of severe pregnancy nausea and vomiting.

Nature geneticsĀ·2026
Same author

A suite of large language models for public health infoveillance.

NPJ digital medicineĀ·2026
Same journal

Covariance decomposition for distance based species tree estimation.

BMC bioinformaticsĀ·2026
Same journal

SNPio: a Python interface for population genomic data processing.

BMC bioinformaticsĀ·2026
Same journal

SpaHNR: a spatial domain identification method via sparse attention-based hierarchical node representation and multi-view contrastive learning.

BMC bioinformaticsĀ·2026
Same journal

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

BMC bioinformaticsĀ·2026
Same journal

NAP: an open source pipeline for cross-domain microbiome profiling using Nanopore sequencing-derived amplicon data.

BMC bioinformaticsĀ·2026
Same journal

SurvGME: an R package for survival analysis with graphical and measurement error models.

BMC bioinformaticsĀ·2026
See all related articles

Related Experiment Video

Updated: Oct 15, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.7K

Deep learning for cancer type classification and driver gene identification.

Zexian Zeng1,2, Chengsheng Mao1, Andy Vo3

  • 1Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 750 N Lake Shore Drive Room 11-189, Chicago, IL, 60611, USA.

BMC Bioinformatics
|October 25, 2021
PubMed
Summary
This summary is machine-generated.

DeepCues, a novel deep learning model, accurately predicts cancer types using raw DNA sequencing data, including germline variants and somatic mutations. This method improves classification and identifies potential cancer-driving genes.

Keywords:
CancerClassificationConvolutional neural networkGermline variantsSomatic mutationWhole-exome sequencing

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

974
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.1K

Related Experiment Videos

Last Updated: Oct 15, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.7K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

974
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.1K

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Genetic information is increasingly vital for cancer type and subtype prediction.
  • Current classification methods often rely on somatic mutations, limiting their scope and power.
  • A need exists for novel methods to integrate diverse genetic variants for enhanced cancer prediction.

Purpose of the Study:

  • To develop a novel deep learning model, DeepCues, for cancer type prediction.
  • To explore the utility of raw DNA sequencing data, including germline variants and small insertions/deletions.
  • To improve feature extraction from genetic data for more accurate cancer classification.

Main Methods:

  • Proposed DeepCues, a deep learning model employing convolutional neural networks.
  • Utilized raw whole-exome sequencing data as input features.
  • Amalgamated germline variants and somatic mutations (including insertions and deletions) for feature generation.

Main Results:

  • Achieved 77.6% overall accuracy in classifying seven major cancer types using TCGA data.
  • Demonstrated significant improvement over conventional methods (p < 0.001).
  • Identified top 20 breast cancer relevant genes with 40% overlap with known driver genes.

Conclusions:

  • DeepCues enhances the representational resolution of DNA sequencing data.
  • The model effectively derives features from raw sequences for cancer type prediction.
  • DeepCues shows promise in discovering novel cancer-relevant genes.